Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

BALA CYNWYD, PA, USA, September 15, 2023/EINPresswire.com/ -- A new advocacy effort is driving change as patients living with herpes globally are rallying for a cure ...

Even though genital herpes is fairly common (roughly one in six Americans has it, according to the Centers for Disease Control & Prevention [CDC]), it's highly stigmatized, in large part because ...

Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus FDA-approved, standard of care treatments Acyclovir and Abreva in a preclinical animal model. In the ...

Assembly Biosciences, Inc. (NASDAQ:ASMB) released interim pharmacokinetic (PK) and safety results from healthy participants in the Phase 1a portion of its ongoing Phase 1a/b study of ABI-5366, an ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ...

Wisp is a telemedicine platform offering sexual and reproductive health services, including online herpes treatment. With both prescription antiviral medications and over-the-counter (OTC) remedies, ...